The signalling (p38 MAPK and PI3K/Akt/mTOR) pathway can control various events in Alzheimer’s and Parkinson’s disease, viz., neuroinflammation, tau phosphorylation, and synaptic dysfunction [161,162]. This evidence concerns the gene AKT1 and Parkinson disease.